Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket

Gainers

• BioNexus Gene Lab Corp BGLC shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported pricing of $5 million public offering and uplisting to the Nasdaq Capital Market.
• Greenbrook TMS Inc. GBNH shares gained 21.2% to $0.40 in pre-market trading. Greenbrook TMS recently entered into equity purchase agreement with Alumni Capital LP.
• Digital World Acquisition Corp. DWAC gained 21% to $16.17 in pre-market trading. Digital World reached settlement with the SEC, paving way for Form S-4 registration statement review.
• Emergent BioSolutions Inc. EBS shares gained 16.2% to $8.20 in pre-market trading after the FDA approved the company's two-dose anthrax vaccine for adults.
• T2 Biosystems, Inc. TTOO shares rose 15.8% to $0.1159 in pre-market trading. The FDA granted Breakthrough Device designation for the company's Candida auris direct-from-blood molecular diagnostic test.
• Phunware, Inc. PHUN rose 11.5% to $0.4321 in pre-market trading. Phunware recently announced strategic cost saving measures to accelerate path to profitability.
• POSCO Holdings Inc. PKX shares rose 11.5% to $108.02 in pre-market trading.
• LiveWire Group, Inc. LVWR rose 10.6% to $11.39 in pre-market trading. LiveWire Group is expected to release its second quarter financial results on July 27, 2023.
• TRACON Pharmaceuticals, Inc. TCON shares climbed 10.2% to $0.32 in pre-market trading. TRACON Pharmaceuticals recently released the results of a six-month independent data monitoring committee (IDMC) review for the ongoing ENVASARC Phase 2 trial.
• Guardforce AI Co., Limited GFAI gained 9.2% to $7.03 in pre-market trading. Guardforce AI shares jumped 57% on Thursday after the company announced it partnered with Concorde Security to launch a new robotic security solution in Singapore.

Losers

• Sigma Additive Solutions, Inc. SASI fell 39.2% to $0.2369 in pre-market trading.
• Kiora Pharmaceuticals, Inc. KPRX fell 15.4% to $0.5320 in pre-market trading. Pharmaceuticals received deficiency letter from NASDAQ. The compliance period for the company will expire on Jan. 15, 2024 - 8K.
• Lytus Technologies Holdings PTV. Ltd. LYT fell 10.8% to $0.49 in pre-market trading after gaining 15% on Thursday. Lytus Technologies recently shared updates on progress on its IPTV and Broadband Services.
• Sirius XM Holdings Inc. SIRI shares fell 9.8% to $7.05 in pre-market trading after gaining 42% on Thursday. Pivotal Research downgraded Sirius XM from Hold to Sell, while Evercore ISI Group analyst Vijay Jayant downgraded the stock from In-Line to Underperform.
• Eliem Therapeutics, Inc. ELYM shares fell 8.7% to $2.72 in pre-market trading. Eliem Therapeutics shares gained over 6% on Thursday after the company decided to explore strategic alternatives.
• Hillstream BioPharma, Inc. HILS fell 8% to $0.3855 in pre-market trading after gaining 10% on Thursday. Hillstream Biopharma recently expanded its collaboration with Minotaur Therapeutics and its license agreement with OmniAb to advance next-generation targeted knob biologics (picobodies) against HER3 and a new undisclosed oncology target.
• DSS, Inc. DSS fell 7.2% to $0.2562 in pre-market trading. DSS recently appointed Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.
• BioSig Technologies, Inc. BSGM fell 7.2% to $1.29 in pre-market trading. BioSig shares gained 7% on Thursday after the company's subsidiary was selected to join NVIDIA Inception program to support R&D collaboration on AI medical device platform for hospitals..
• Advanced Health Intelligence Ltd. AHI shares fell 6.1% to $3.91 in pre-market trading after gaining over 22% on Thursday.
• Intuitive Surgical, Inc. ISRG fell 4.8% to $331.00 in pre-market. Intuitive Surgical reported better-than-expected earnings for its second quarter.

Now Read This: American Express, SLB And 3 Stocks To Watch Heading Into Friday